Jin Medical International Ltd.
For the period ended Jun 29, 2026. Filed Jun 29, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Jun 29, 2026 · Filed Jun 29, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · 5.2 Authority; Binding Effect
5.2 Authority; Binding Effect
The Target has full corporate power and authority to execute and deliver each Transaction Document to which it is a party and to perform its obligations thereunder. The Seller has full legal capacity and authority to execute and deliver each Transaction Document to which he is a party and to perform his obligations thereunder. Each Transaction Document executed by the Seller or the Target constitutes, or upon execution will constitute, a legal, valid and binding obligation of such Person, enforceable against such Person in accordance with its terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws affecting creditors’ rights and to general principles of equity.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.